Sodium in the dermis colocates to glycosaminoglycan scaffold, with diminishment in type 2 diabetes mellitus by Hanson, Petra et al.
Sodium in the dermis colocates to glycosaminoglycan scaffold,
with diminishment in type 2 diabetes mellitus
Petra Hanson, … , Galina E. Pavlovskaya, Thomas M. Barber
JCI Insight. 2021;6(12):e145470. https://doi.org/10.1172/jci.insight.145470.
 
BACKGROUND. Dietary sodium intake mismatches urinary sodium excretion over prolonged periods. Our aims were to
localize and quantify electrostatically bound sodium within human skin using triple-quantum–filtered (TQF) protocols for
MRI and magnetic resonance spectroscopy (MRS) and to explore dermal sodium in type 2 diabetes mellitus (T2D).
METHODS. We recruited adult participants with T2D (n = 9) and euglycemic participants with no history of diabetes
mellitus (n = 8). All had undergone lower limb amputations or abdominal skin reduction surgery for clinical purposes. We
used 20 μm in-plane resolution 1H MRI to visualize anatomical skin regions ex vivo from skin biopsies taken
intraoperatively, 23Na TQF MRI/MRS to explore distribution and quantification of freely dissolved and bound sodium, and
inductively coupled plasma mass spectrometry to quantify sodium in selected skin samples.
RESULTS. Human dermis has a preponderance (>90%) of bound sodium that colocalizes with the glycosaminoglycan
(GAG) scaffold. Bound and free sodium have similar anatomical locations. T2D associates with a severely reduced
dermal bound sodium capacity.
CONCLUSION. We provide the first evidence to our knowledge for high levels of bound sodium within human dermis,
colocating to the GAG scaffold, consistent with a dermal “third space repository” for sodium. T2D associates with
diminished dermal electrostatic binding capacity for sodium.
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Introduction
Established dogma adopted nearly 40 years ago (1) states that urinary sodium output matches dietary sodi-
um intake in normal human physiology. This traditional model of  sodium homeostasis locates sodium ions 
primarily within the extracellular fluid (ECF) compartment, which — together with the intracellular fluid 
(ICF) compartment — forms the traditional “2-space” model for sodium homeostasis. Furthermore, unlike 
other essential minerals and nutrients (such as calcium, iron, fatty acids, or glucose), no storage facility 
exists for excessive sodium ions, which are simply excreted in the urine.
Recently, our understanding of  human sodium homeostasis has been transformed by insights from 
data that have emerged from the Mars program (led collaboratively by the National Aeronautics and 
Space Administration [NASA] and scientists from the European Union [EU] and Russia), conducted 
as part of  preparation for the prolonged zero-gravity of  flights to Mars (2). Due to potential concerns 
regarding electrolyte imbalances that may ensue, careful sodium balance studies, performed as part of  this 
program on young healthy cosmonauts during studies in sealed metabolic units (2, 3), included prolonged 
studies (over many days and weeks) on urinary sodium excretion in response to diets that contain variable 
(but precisely measured) sodium contents. For the first time to our knowledge, data from these studies 
demonstrate, in humans, the existence of  ultra-long (including infradian) rhythmic variations in urinary 
sodium excretion (4). Importantly, these rhythms occurred despite maintenance of  a constant dietary 
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sodium intake (3, 5). In addition to there being an apparent mismatch between dietary sodium intake and 
urinary sodium excretion over many days and weeks, another observation was that, for those cosmonauts 
on a high-sodium diet, there was apparent retention of  sodium without associated weight gain (3). This 
observation is important, as it challenges established dogma that states that, in normal physiology, reten-
tion of  sodium always associates commensurately with retained water (through osmosis), thereby also 
influencing body weight.
Despite inherent difficulties of  imaging sodium ions (6, 7), recent data stemming from use of  23Na 3 Tesla 
(3T) MRI reveal a preponderance of  sodium signals from the human skin (8, 9). These human-based studies 
corroborated data from prior rodent-based studies (10). Further preliminary data in human chronic kidney 
disease (CKD) suggest that sodium content within the skin closely associates with left ventricular mass and 
systolic blood pressure (9, 11). It has even been suggested that the location of  sodium within the skin may 
strengthen the antimicrobial barrier function of  skin and boost macrophage-driven host defence (12).
While 23Na MRI methods have been important in numerous attempts to quantify the levels of  sodium 
in human skin noninvasively (13–16), implementation of  this in vivo imaging methodology in the clinical 
arena has yet to occur. Although elevations in skin sodium concentrations have been reported in patients 
with CKD and hypertension (17 18), data from such studies were obtained using whole body scanners 
with reported sodium levels ≤ 30 mM for various pathologies (19–21). Unfortunately, this threshold is well 
below that typical of  ECF sodium concentration (up to 130 mM; ref. 22).
Our aim was to generate data to provide the first accurate anatomical localization and quantification 
of  free and electrostatically bound sodium within human skin ex vivo. A further aim was to develop novel 
insights into the dynamics of  sodium within human skin, and the influence of  type 2 diabetes mellitus (T2D).
To enable 23Na MRI and 23Na magnetic resonance spectroscopy (MRS) protocols for these aims, we 
implemented the following steps. (a) Biopsy skin samples were used for microimaging at 9.4 Tesla magnetic 
field strength, to enable a much higher spatial resolution than that typically achievable using whole body 
MRI. Furthermore, the ex vivo conditions facilitated protocol development due to reduced time and regu-
latory constraints. (b) The skin specimens were vacuum packed for sample preservation without chemical 
treatment that would otherwise have affected sodium dynamics and concentration in the tissue. (c) We 
utilized multiple quantum filtered (MQF) 23Na MRI to discern the localization of  the bound ionic sodium 
from the free (dissolved) one in the skin. (d) The relative quantification between the 2 types of  sodium states 
(bound and free) was obtained using 2-dimensional triple quantum time-proportional phase incrementation 
(TQ-TPPI) 23Na MRS.
Concepts of  TQ tagging of  bound sodium. Sodium in Figure 1A exists either in the form of  dissolved ions 
(i.e., free sodium) within the ECF space where it undergoes rapid Brownian motion, or it is electrostatically 
bound to specific electronegative sites of  macromolecules (i.e., bound sodium), in which state the 23Na 
motion is reduced substantially. At sites with slow exchange rate, there is fixation of  the sodium ions for the 
duration of  the MRI measurement (timescale of  hundreds of  milliseconds, indicated by small arrowheads), 
even when multiple exchanges occur during the measurement period, and the net 23Na motion may be 
slowed substantially compared with that of  the free ions. For this study, we consider sodium that undergoes 
slow exchange in the ways described here as bound sodium.
The ability to distinguish between free and bound sodium in magnetic resonance (MR) measure-
ments arises from the high nuclear spin (S = 3/2) of  23Na. A TQ coherence can be induced through spe-
cific MR protocols if  the 23Na is electrostatically bound to a large molecular environment that imposes 
a slow-motional state for the sodium. Since it is not possible to generate TQ coherence in fast-moving 
free sodium ions (i.e., for 23Na in a fast-motion state), it is possible to use this difference in signal to 
“tag” specifically bound sodium. In addition, TQ-TPPI 23Na MRS, illustrated in Figure 1B, enables 
quantification of  the ratio of  bound to free sodium (23, 24). Similarly, insertion of  a TQ filter (TQF) 
into sodium MRI protocols suppresses all signals except TQ-tagged 23Na; recorded MRI depicts bound 
sodium only. TQF MRI and TQ-TPPI MRS are well developed and understood (23, 25) and have been 
utilized previously in biomedical studies to distinguish between sodium within the ICF and ECF in 
cell suspensions spectroscopically (26) and visualized using TQF 23Na MRI in the brain (27, 28), in the 
muscle (29), and in the cartilage (30). Furthermore, standard gradient echo (GE) 23Na MRI protocols 
largely suppress signals arising from bound sodium due to its inherent fast T2 relaxation. Therefore, 
GE-based 23Na MRI protocols used in the clinical setting predominately reveal signals from free sodium 
ions, whereas TQF 23Na MRI localizes bound sodium.
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Results
To discern the location for bound sodium within the skin, high in-plane resolution (up to 20 μm) 1H MRI 
was performed on selected skin biopsies, since the outcomes of  high resolution 1H MRI were similar to each 
other. MRI allowed for clear identification of  the major regions of  the skin (epidermis, dermis, s.c. fat layer, 
and the microvasculature), as shown in Figure 2, A and B. As the echo time was increased in the specialized 
T1 weighted/T2* MRI protocol, the skin regions with decreased water mobility were further highlighted, as 
shown in Figure 2, C and D; the darker layer was identified as dermis in both control and diabetic skin biop-
sy samples. Collecting a few more echoes during this protocol allows one to convert echo images into T2* 
contrast images, shown in Figure 2, E and F. Further analysis of  T2* distributions in skin biopsies from both 
control and diabetic cases revealed similar characteristics regarding fat and labile water compartments. How-
ever, images from the control skin biopsies also revealed the presence of  extremely immobile water (with 
T2* of  approximately 5 ms), a feature that was absent in the diabetic skin biopsies, as shown in Figure 2, G 
and H. The extremely immobile water observed in the control skin biopsies most likely originated from the 
dermis layer, as reflected by the T2* color map, over-layered with a corresponding anatomical intensity map.
To achieve coregistration of  free and bound sodium with both skin anatomy and histology, we per-
formed ultra–high-resolution proton scanning of  a selected skin biopsy from a participant with T2D and 
histological glycosaminoglycan (GAG) staining of  a selected skin biopsy obtained from a control partic-
ipant. The resultant anatomical 1H MRI slice is displayed in Figure 3A, extracted from the center of  the 
Figure 1. Concept of identification of bound-state sodium ions through TQF 23Na MRI and TQ-TPPI 23Na MR Spectros-
copy. (A) Possible interactions of sodium ions (23Na+) with electro-negative sites of a glycosaminoglycan (GAG), such as 
dermatan sulphate. Yellow indicates dissolved (i.e., free) sodium ions; orange indicates 23Na+ in a bound or temporary 
bound state with the macromolecule. (B) Analogous to clinical and preclinical 1H MRI, 23Na MRI generates and detects 
single quantum coherence. However, the physical property of the 23Na nuclei also enables temporary generation of a TQ 
coherence through specific MR protocols if the sodium is bound to a slow motional molecular environment. Both, TQ-TP-
PI spectroscopy (shown here) and TQF MRI utilize the different properties of single quantum (SQ) and triple quantum 
(TQ) coherence for the differentiation between slowly moving bound sodium and rapidly moving free sodium ions.
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MRI multislice package with geometry axes. Figure 3B displays histological GAG staining of  a skin speci-
men obtained from NDB8 and shows the overlay of  the histology slide with ultra–high-resolution 1H MRI 
that demonstrates that stained GAGs shown in the histology slide colocalize with the dermis layer in the 
MR slide. Figure 3, C and D, display localization of  free and bound sodium, respectively, and their overlay 
with 1H MRI skin anatomy. As one can see from Figure 3, both free and bound sodium colocalize with the 
dermis layer in the MRI slide, where GAGs are typically located, as determined by histological staining. 
We observed similar patterns for both free and bound sodium in nondiabetic skin biopsies (Supporting 
Information, Supplemental Figures 1–3; supplemental material available online with this article; https://
doi.org/10.1172/jci.insight.145470DS1). Sodium levels were expressed in sodium signal/noise ratios 
(SNRs) to account for variations in the signal to noise. SNR-based approaches for quantifying sodium 
levels in tissues were reported before by other research groups (20, 31).
We performed 23Na MRS and MRI scans in all harvested skin biopsies. We show phenotypic details 
of  the patients who donated skin biopsy samples in Table 1. Sodium storage within each skin biopsy was 
further quantified by determining the fraction of  sodium that would be in the bound state using 2-dimen-
sional TQ-TPPI 23Na MRS (23 25), in the statistically significant pool of  skin biopsies collected from 
patients (regardless of  their T2D status). We performed sodium localization in all harvested skin biopsies 
prior to the application of  TQ-TPPI 23Na MRS protocol. The images demonstrated sodium signals in 
similar locations, with typical examples for control (NDB7) and diabetic (DB9) skin biopsies shown in 
Figure 4, A and D, respectively. The resultant 2-dimensional sodium TQ-TPPI spectra for the skin sam-
ples imaged in Figure 4, A and D, were collected under 2 minutes and are displayed in Figure 4, B and E, 
for control and diabetic skin samples, respectively. Both 2-dimensional spectral maps were characterized 
by 2 signals indicative of  sodium being present in both its free and bound states within each skin sample. 
As demonstrated from the images, about 90% of  sodium recorded by the standard 23Na GE MRI proto-
col was localized in the dermis layer. Therefore, the highlighted sodium dynamics most likely originate 
from the dermal layer of  the skin. For clarity, we further deduced the dynamics of  this process through 
analysis of  individual traces extracted from these 2-dimensional spectral maps at the zero frequency off-
set, as shown by dashed arrows in Figure 4, C and F. The sodium signals appearing at 3000 Hz in these 
individual traces reflected the amount of  bound sodium, while the sodium signals appearing at 1000 
Hz were indicative of  sodium in its free state. As shown by the horizontal arrows, there is a diminished 
bound sodium content in T2D compared with controls. To test this hypothesis, fractions of  bound and 
free sodium were determined from the areas of  sodium peaks at 3000 Hz and 1000 Hz, respectively, by 
fitting each line shape to a Lorentzian function (32). The ratio of  bound to free sodium was determined 
for most of  the biopsies as shown in Table 1, and statistics of  all data are displayed in Figure 5.
As observed from Figure 5A, there is diminishment of  the free sodium fraction, or “sodium release” in 
control skin biopsies. Conversely, there is diminishment of  the bound sodium fraction in the diabetic skin 
biopsies. Furthermore, the bound/free sodium ratio (shown in Figure 5B), is clearly higher for the control 
versus the diabetic skin biopsies, consistent with a diminished electrostatic binding capacity for sodium 
within the skin dermis layer from patients with T2D, compared with that from control nondiabetic patients. 
This difference in electrostatic binding capacity for dermal sodium between T2D and controls was indepen-
dent of  the anatomical location of  the skin biopsy, as skin biopsy data from both abdominal and lower limb 
regions contributed to the statistical analyses displayed in Figure 5.
Through conversion of  sodium image intensity into sodium concentration (assuming almost complete 
bound sodium signal loss and almost full signal recovery from the free sodium when GE 23Na MRI is used 
for image acquisition, and, conversely, assuming almost complete signal recovery of  the bound sodium and 
full suppression of  free sodium signal with the TQF is incorporated into the MRI protocol), it was possible 
to obtain absolute quantification of  sodium from sodium MRI images, both in its free state within the ECF 
and electrostatically bound within the skin dermis layer. We based this conversion on assumptions that 
almost complete bound sodium signal loss with almost full signal recovery from free sodium loss occurs 
during GE 23Na MRI and that almost no bound sodium signal is lost with application of  the TQF 23Na 
MRI protocol, which suppresses free sodium signal completely.
We performed sodium imaging in 3 separate diabetic skin biopsies harvested from 2 patients (DB6 and 
DB7), together with known sodium standards for calibration, as shown in Figure 6. As shown in the images, 
maximum sodium skin concentration was determined to be 41 mM, a much lower value than 76 mM, which 
is a mean estimate of  sodium skin concentration derived from measurements on DB6 and DB7 skin samples 
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(Table 2). We derived the maximum sodium skin concentration from the same skin samples (DB6 and DB7) 
using the technique of  inductively coupled plasma mass spectrometry (ICPMS, as described in Methods). 
Dermal sodium levels determined using in vivo MRI were reported to be < 30 mM (18, 20, 33). We attribute 
the higher levels of  sodium obtained from our study to the finer resolution of  our measurements and, hence, 
Figure 2. Comparison of T2* maps between control and diabetic skin biopsies for mobile and immobile (bound) water. (A and B) Anatomical compartments 
of human the skin using 1H 9.4T MRI, approaching histological length scales (20 μm) for control (NDB2) and diabetic (DB3) skin biopsies. (C and D) Segmentation 
of skin dermis layer in control (C) and diabetic (D) biopsies with the increase of TE to 8 ms. (E and F) T2* maps for control (E) and diabetic (F) cases overlaid with 
anatomical slides to highlight areas of s.c. adipose tissue (long T2* values) and aqueous phase (short T2* values). (G and F) Distributions of T2* values associated 
with each phase are shown in G for control and in H for the diabetic biopsy. Note the appearance of immobile or bound water at T2* = 5 ms in the control biopsy.
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better segmentation of  the skin dermis layer where there is predominant location of  sodium, compared with 
those obtained from in vivo techniques. However, the sodium concentration of  41 mM in the skin dermis 
layer obtained in Figure 6, through comparison with known sodium standards, is still much lower than the 
skin sodium concentration of  76 mM, determined by ICPMS as the mean average of  2 samples extracted 
from 2 diabetic patients (Table 2). The fact that both sodium levels obtained from prior in vivo MRI, and free 
sodium levels derived from MRI of  skin samples reported from our own study, are lower than the gold stan-
dard measurements most likely reflect loss of  signal from bound sodium during GE 23Na MRI collection. 
As explained above, visualization of  bound sodium requires incorporation of  TQF into the sodium imaging 
protocol, and we show that the fraction of  bound sodium quantified by sodium TQ-TPPI MRS (Figure 4 
and Figure 5) appears to be significant. Therefore, image collection using a vendor optimized for a clinical 
imaging standard sodium GE protocol visualizes predominately free sodium in tissues and results in under-
estimation of  sodium concentration within the skin as previously reported by other research groups (31).
Figure 3. Illustration of 23Na MRI biopsy. (A) Photograph of a typical skin sample with indication of MRI axial view, left, 
and a high-resolution 1H MRI slice (11 × 11 × 100 μm3, axial view) showing the anatomy of the DB9 skin sample (right). 
(B) Histological GAG staining of typical skin specimen (i.e., harvested from NDB8) (left) and histology slice scaled to 
match the scale of the 1H MRI slice of DB9 to demonstrate that GAGs are localized predominantly in the dermis layer 
(right). The boundary of the dermis layer is indicated with red line, while blue line reflects the depth of GAG staining 
determined from histology. (C) Localization of free sodium in DB9 obtained through 23Na MRI (left) and its overlay with 
skin anatomical 1H MRI slice of DB9 (right). (D) Localization of bound sodium in DB9 obtained through TQF 23Na MRI 
(left) and its overlay with skin anatomical 1H MRI slice of DB9 (right). Note that free and bound sodium coregister pre-
dominantly with the dermis layer where GAGs are located. Sodium concentrations are expressed through the observed 
23Na signal/noise ratios (SNRs).
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Incorporation of  the optimized maximal bound sodium image quality TQF (Supporting Information, 
Supplemental Figure 2) into the sodium imaging protocol (32, 34) allows one to visualize bound sodium 
deposition within the skin, as shown in Figure 6 (right). Using the same calibration standards as in the 
case above, we estimate that the maximum bound sodium is at a level of  26 mM. Adding these 2 numbers, 
one arrives at a value of  67 ± 7 mM for total sodium concentration using MRI saline standards (Figure 
6), compared with 76 ± 5 mM as determined by ICPMS. We note the absence of  sodium signals from the 
standards in the bound sodium images (Figure 6, right), which indicates that sodium signals originating 
from a liquid (or in the case of  a skin biopsy, ECF) are removed as intended. Therefore, following the 
addition of  the TQF to the imaging protocol, skin biopsy MRI indeed visualizes only bound sodium.
Discussion
The use of  vacuum-packed skin samples in the present study enabled insight into the structure of  human 
skin at a resolution of  tens of  microns, approaching histological-length scales. Previous comparisons of  vac-
uum-packed cartilage samples and their subsequent histology after MRI experiments demonstrated that the 
tissues remain in a viable state after being vacuum packed and refrigerated for up to 7 days (35). Since vac-
uum-packed materials were not exposed to any additional treatment, we believe that this method of  tissue 
transport enabled capture of  the dynamics of  water distribution and sodium deposition in control and diabet-
ic skin samples similar to that in vivo. The < 20 μm 1H MRI allowed for anatomical resolution of  the different 
skin regions, and similar structural compartments were identified in vivo (36). In contrast, the T2* 1H MRI 
contrast imaging demonstrated the presence of  immobile (T2* = 5 ms) water in the nondiabetic skin biopsies, 
localized to the layer of  the dermis. This type of  water was absent in the diabetic biopsies. While this result is 
promising and may represent a pathophysiological feature of  T2D, the translation of  this concept into a clin-
ical setting is difficult. Due to its nature, the T2* 1H MRI contrast is more pronounced at a higher magnetic 
field strength (i.e., 9.4 Tesla magnetic field strength used in the present study) and diminishes with reductions 
in the field strength. Given the operational strength of  a clinical MRI scanner being up to 3 Tesla, T2*-associ-
ated features most likely will not be observable using such scanners (37).
The quest for the identification of  pathophysiological features of  T2D using sodium signals has great 
potential for clinical translation, as the typically applied magnetic field strength only partially affects sodi-
um T2 relaxation. We visualized sodium in both its free and bound states using sodium MRI. The usage 
Table 1. Skin donor information
Reference number Age Sex Harvest site Number of samples Number of TQ-TPPI 
repeats
Control Group
NDB1 62 Female Abdomen 2 0
NDB2 46 Female Abdomen 2 2
NDB3 33 Female Lower limb 4 4
NDB4 49 Female Abdomen 2 2
NDB5 53 Female Abdomen 2 0
NDB6 27 Female Abdomen 2 0
NBD7 74 Female Lower limb 2 2
NDB8 66 Male Lower limb 2 4
Type 2 Diabetes Mellitus Group
DB1 61 Male Lower limb 2 1
DB2 71 Male Lower limb 1 1
DB3 73 Male Lower limb 2 2
DB4 56 Male Lower limb 2 2
DB5 61 Male Lower limb 2 4
DB6 52 Female Lower limb 2 1
DB7 84 Male Lower limb 2 3
DB8 Unknown Female Lower limb 2 3
DB9 Unknown Male Lower limb 2 2
The last column shows random repeats of TQ-TPPI experiments, used to determine the storage capacity of skin.
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of  the TQF 23Na MRI protocols to detect bound sodium is well established (27, 28, 30, 32). As outlined 
above, sodium in fast exchange with macromolecules may transfer some TQF signals into the dissolved 
state of  free sodium (see ii in Figure 1A), thereby potentially resulting in an overestimate of  bound sodium 
quantity. This effect is likely present in the intracellular space and is previously used to distinguish between 
intra- and extracellular sodium (26).
The ratio of  bound/free sodium is usually substantially lower than that reported in our study. Schepkin 
et al. calculated the bound sodium signal in an in vivo rat brain to be about 16% of  that arising from free 
sodium (25), almost identical to that shown in an agarose tissue model (24). In our reported study, the sig-
nal from bound sodium in the skin dermis layer was about 90% (median value in controls), with the remain-
ing sodium signals originating from free sodium. Therefore, our data reveal > 5-fold greater bound sodium 
Figure 4. Axial localization of sodium using 23Na GE protocol. (A and D) The control (NDB7) (A) and diabetes (DB9) 
(D) skin biopsies. (B and E) Two-dimensional 23Na TQ-TPPI maps for control (B) and diabetic biopsy (E) using the 
same samples as in A and D. (C and F) Individual zero frequency traces for control (C) and diabetes (F) showing free 
(1000 Hz) and bound (3000 Hz) sodium signals. Note, relative to the free sodium, there is lower sodium storage in 
diabetes than in the control.
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within the skin dermis layer compared with that in other organs shown in previously published studies 
(25). This observation strongly suggests that, within the skin dermis layer, a high proportion of  bound state 
sodium indeed occurs, without any attendant osmotic effects, or at least with only a minimal osmotic effect 
from bound sodium undergoing exchange with free sodium. We hypothesize that a substantial fraction 
of  the bound sodium signal from the skin dermis layer, which is largely void of  intracellular space, origi-
nates from stored sodium. We provide further support for this interpretation in Figure 6. Such reversal in 
intensity contrast for bound and free sodium would be unlikely if  the TQF MRI signal is caused by rapidly 
exchanging sodium ions in the intra- or extracellular fluid, as in this scenario the areas of  “bound” and free 
sodium should be identical. Further investigation of  this phenomenon is, therefore, important and may 
provide additional valuable insight into the regional sodium deposition in the skin in health and disease. 
This aspect of  investigation was outside the scope of  the current work.
We further probed the dynamics of sodium binding or, as we hypothesize, storage using sodium MRS. 
Vacuum-packed samples provided a unique opportunity for this endeavor, given the absence of any additional 
sodium treatment introduced into the biopsied skin samples. The coregistration of proton and sodium images 
allowed us to visualize 23Na presence at the < 20 μm length scale. This confirmed that free sodium locates most-
ly within the dermis layer of the skin and where, according to histology, GAGs are located (Figure 3). More-
over, we localized bound-state sodium predominately within the dermis layer of the skin for both control and 
diabetic skin biopsies. Through analysis of both free and bound-state sodium spaces in the control and diabetic 
skin samples, we demonstrated that sodium release into its free state predominates within the skin samples 
from patients with T2D, whereas reverse sodium transfer into its bound state predominates in the skin samples 
from control nondiabetic patients. Our data align with previous in vivo observations suggesting that overall 
levels of skin sodium (probed by 23Na MRI) are higher in diabetes mellitus (DM) (18, 20), as the sodium MRI 
used in clinical practice is sensitized toward free sodium and suppresses the signal from bound sodium that 
requires a TQF MRI protocol to be visualized (32). Therefore, it appears that the higher sodium levels observed 
within the skin of patients with DM, as reported from prior 23Na MRI observation (18, 20), may in fact result 
from the detection of an increased fraction of free sodium. The ratio of bound/free sodium reflects the storage 
capacity for sodium within the skin. Due to the hypothesized reduction in the storage capacity for sodium with-
in the skin dermis layer of patients with T2D, this allows for greater availability of free sodium, observed using 
clinical sodium MRI protocols. Importantly, our data confirm that total sodium levels in the skin dermis layer 
are equivalent between control and diabetic skin biopsies, as shown by ICPMS analysis in Table 2.
Recent work (38) suggested that sodium levels in skin biopsies extracted from CKD patients and con-
trols were similar. Though we performed ICPMS only in one control sample, we demonstrated that the 
Figure 5. Wilcoxon signed-rank statistics of free and bound sodium fractions. Wilcoxon signed-rank statistics of free and bound sodium fractions deter-
mined from 2-dimensional 23Na TQ-TPPI maps, and of skin sodium binding capacity, defined as bound to free sodium ratio, for control (n = 14 collected 
from 5 patients) and diabetic (n = 19 collected from 9 patients) skin biopsies. (A) Compared with T2D, control skin samples had greater retention of free 
sodium release, with P < 0.05, while there is an increase in bound sodium in controls, with P < 0.05. (B) There is augmentation of skin sodium binding 
capacity for skin samples from controls versus those from patients with T2D, with P < 0.05, as shown in B.
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average sodium concentration, determined from 3 samples taken from different regions of  the skin dermis 
layer, was 79.8 ± 5.0 mM compared with 75 ± 5.0 mM for the diabetic biopsies, again showing that total 
sodium levels in the skin dermis layer are similar in both cases. We hypothesize that multiple factors influ-
ence the proportion of  sodium in its free and bound states. The former sodium state localizes within the 
interstitial fluid of  the dermal extracellular matrix (ECM); we hypothesize that the latter complexes with 
the negatively charged sites of  the GAG scaffold within the skin dermis layer. These factors include tem-
perature and vascular and lymphatic flow.
Observations from the Mars program (including mismatches between daily sodium intake and urinary 
excretion of  sodium, as well as mismatches between net sodium status and body weight through retained 
sodium) cannot be explained through our traditional physiological understanding of  the “2-space” mod-
el of  human sodium homeostasis, implicating the 2 compartments of  ICF and ECF (1). Our reported 
data challenge this traditional model of  human sodium regulation, at least ex vivo. A more sophisticated 
model of  sodium homeostasis is required — one capable of  providing an explanation for the mismatches 
between sodium intake and excretion and between net sodium status and body weight observed in the 
Mars program. This model of  sodium homeostasis invokes the existence of  a third space repository (TSR) 
for sodium ions, capable of  storing sodium ions in a location that is both osmotically and electrostatically 
inert, and separate and distinct from both the ECF (16) and the ICF. A “third space” model of  human 
Figure 6. Quantification of free and bound sodium levels obtained from sodium imaging standards for 3 biopsies 
collected from 2 different patients. Note complementary inverse contrast converted to sodium levels in mM. Free and 
bound state sodium are indicated by red arrows. This implies heterogeneity of sodium deposition in the skin. Note the 
bound sodium in the endothelial tissue of large blood vessel shown in the right middle panel. We indicate the random 
noise registered at sodium frequency by blue arrows. Sodium levels are determined within ± 7 mM using saline standards.
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sodium regulation would be entirely consistent with the observations from the Mars program. These 
include the storage of  sodium without associated weight gain, and mismatches between dietary sodium 
intake and urinary sodium excretion, each of  which would be permissible and indeed predictable from a 
“third space” model of  sodium homeostasis.
From an evolutionary perspective, a “third space” model of  sodium homeostasis with a TSR for sodi-
um would be entirely logical and similar to storage repositories for other essential minerals and nutrients 
(such as calcium and fatty acids within the skeleton and adipose tissue, respectively). Such repositories 
enable potentially life-saving supplies of  essential minerals and nutrients to the body in times of  need — 
during starvation, for example. Given the central role of  sodium in the maintenance of  an adequate blood 
volume, a TSR for sodium would serve as a source of  sodium for the ECF in times of  acute loss of  sodium, 
such as occurs during diarrhoeal illness or catastrophic blood loss. In such scenarios, release of  arginine 
vasopressin (AVP) in response to movement of  sodium ions from a TSR to the ECF would mitigate against 
loss of  plasma volume through renal retention of  water. This mechanism would confer substantial survival 
and, therefore, evolutionary advantage. Conversely, any compromise of  the TSR for sodium would likely 
associate with a commensurate increase in free sodium within the ECF, as well as with promotion of  hyper-
tension and adverse cardiovascular sequelae.
Based upon the presented experimental evidence that bound sodium locates mostly within the skin dermis 
layer, we propose that, given the high negative charge of the dermal GAG scaffold, this would attract electro-
statically and bind positively charged sodium ions naturally from their free state within the surrounding and 
contiguous ECF. In this way, the GAG scaffold within the skin dermis layer, located within the ECF itself, 
would function as a natural TSR for stored sodium. Bound sodium stored within the proteoglycan matrix of the 
GAG scaffold of the skin dermis layer could exchange with the surrounding unbound and free sodium within 
the ECF; however, this exchange would be limited to the ECF pools encapsulated into gaps formed by proximal 
GAG chains. Hence, we envision that only a proportion of bound sodium stored within the skin dermal layer 
GAG scaffold would participate in this exchange and that the sodium “captured” by the GAG network is best 
defined as stored sodium. To change the capacity for sodium storage within the skin dermal layer GAG would 
require remodeling of negatively charged sites. Such remodeling could result from a change in the GAG confor-
mation due to exposure to altered calcium levels, for example (39). Alternatively, a change in the production of  
GAGs and their polymerization (40) could result in a change to the number of possible sodium exchange sites 
and their exposure to the surrounding ECF. Greater extension of the GAG scaffold into the surrounding ECF 
would likely increase its overall storage potential for sodium. Our data suggest that control nondiabetic skin 
associates with optimized storage capacity for sodium within the skin dermis layer. Conversely, we hypothesize 
that a possible structural change and/or reduced production of the dermal GAG in patients with T2D results 
in diminished storage capacity for bound sodium. It has also been proposed that the GAG complex within the 
endothelial layer may act as an intravascular buffer that enables transient storage of sodium (41, 42).
Table 2. ICPMS data for selected skin biopsies.
Sample list Sample number Donor number Sample type Weight (mg) Volume (mL) Na (mg/kg) Na 
(mM)
Skin biopsy 1 1 DB6 Fat 370.3 50 436 18.96
Skin biopsy 2 2 DB6 Skin 234.9 50 1805 78.46
Plasma 3 3 DB6 Liquid 374.7 10 2980 129.62
Skin biopsy 4 4 DB7 Fat 401.8 50 248 10.78
Skin biopsy 5 5 DB7 Skin 364.4 50 1684 73.25
Plasma 6 6 DB7 Liquid 180.9 10 2931 127.45
Skin biopsy 7 7 NDB8 Skin 0.2 50 1698 73.83
Skin biopsy 8 8 NDB8 Skin 0.15 50 1920 83.46
Skin biopsy 9 9 NDB8 Skin 0.22 50 1889 82.11
Plasma 10 10 NDB8 Liquid 0.19 10 3052 132.69
Please note the sodium concentration (in mM) within ± 5 mM from the determined sodium concentration (in mg/kg). The discrepancy arises from the 
uncertainties in densities of the tissues, as the density of different tissue compartments was not determined in this study. The estimate comes from the 
reported values of densities for human dermis and s.c. adipose tissue.
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Unlike free sodium within the ECF and ICF, bound and stored sodium within the skin dermis layer 
TSR would not have osmotic effects and, therefore, would not associate with either peripheral oedema 
or deleterious hemodynamic effects. This would help to explain the observations from the Mars program 
regarding mismatched net sodium intake and body weight (from retained water through osmotic effects) 
(3, 40). The GAG scaffold within the skin dermis layer provides an ideal location within the ECF to act as 
an effective buffer for sodium overload in conditions that associate with sodium retention. Furthermore, 
the dermal TSR for sodium also provides an ideal location for the release of  bound stored sodium to its 
free state into the surrounding ECF, at times of  acute sodium loss and need (following diarrhoeal illness 
or acute blood loss from trauma, for example). At such times, we hypothesize that stored sodium ions 
might simply migrate from the dermal TSR into the surrounding ECF — possibly through the collapse of  
GAG chains within the skin dermis layer, thus decreasing the number of  negatively charged sites available 
for sodium complexation — and by implication resulting in a diminished dermal TSR for sodium. Once 
released from its bound stored form, sodium would exist in the ECF in its usual free (unbound) state and, 
through osmotic and AVP-related effects, enable restoration of  a functional ECF and plasma volume. We 
also hypothesize that a dermal TSR for sodium would act as a buffer to protect the surrounding ECF and 
plasma volume from the potentially deleterious osmotic and hemodynamic effects of  excessive unbound 
sodium, and we hypothesize that it would provide a mechanism to accommodate large quantities of  
exchangeable bound sodium resulting from chronic sodium retention, as often occurs in DM (43). The 
dermal sodium TSR is a dynamic structure, and its dynamic amplitude may provide a useful marker of  
pathology, including, for example, heart failure (44).
To summarize, we provide the first evidence to our knowledge for high levels of  bound sodium within 
human skin dermis layer, colocating to the GAG scaffold, and we provide support for the hypothesis that at 
least 40% of  dermal sodium — that exists within a TSR — is bound and stored in the dermis. Furthermore, 
we also provide the first evidence to our knowledge for an association between T2D and a compromised 
dermal binding capacity for sodium. Our study highlights the importance of  full characterization and quan-
tification of  dermal sodium using sufficiently powerful MRI techniques, for proper and accurate evaluation 
of  bound dermal sodium. Unfortunately, application of  sodium MRI techniques used in clinical practice 
typically lack sufficient power to enable such accurate measures of  dermal sodium because signals arising 
from bound sodium usually remain silent. Given the technical difficulties of  localizing a TSR for sodium 
using clinical MRI scanners, including image resolution and scan time, we propose a revision of  sodium 
acquisition strategies for routine clinical purposes. This is especially relevant in the application of  such 
techniques for the interpretation of  skin sodium levels in patients with DM. A major challenge would be 
in the translation of  2-dimensional 23Na MRS like TQ-TPPI to in vivo clinical scanners, though this task is 
technically achievable. The benefit of  this technological investment would be the delivery of  a clinically rel-
evant noninvasive sodium protocol that could accurately quantify bound sodium within the dermis within 
minutes, thereby providing insight into the capacity of  the dermal TSR for sodium in patients with DM and 
other medical conditions. The availability of  such a clinical tool would provide invaluable insight into the 
sodium status of  patients throughout the entire realm of  clinical medicine and help to inform appropriate 
and timely management, thereby improving patient care and saving lives. Data from such a tool would also 
inform future guidance on the effective management of  sodium homeostasis in patients with DM and other 
relevant conditions.
Methods
Study design. The skin samples were obtained from patients with a confirmed diagnosis of  T2D (n = 9) and 
control patients with no known history of  DM (n = 8); phenotypic details are shown in Table 1. All skin 
samples derived from patients with T2D came from the lower limb. For the controls, skin samples came 
from the abdomen (n = 5) and lower limb (n = 3). Lower-limb amputations and abdominal surgery were 
performed for clinical reasons. We only derived skin samples from normal skin (proximal to any area of  
infection or necrosis in the case of  amputations), confirmed both macroscopically and with histological 
examination. Regarding glycemic therapies at the time of  skin resection, most of  the patients with T2D (n 
= 6) were on insulin therapies; one of  the patients was taking a sodium glucose-like transporter 2 (SGLT2) 
inhibitor, metformin, and a glucagon-like peptide 1 (GLP1) agonist therapy, and one was taking a sulpho-
nylurea and dipeptidyl peptidase 4 (DPP4) Inhibitor therapy. Regarding antihypertensive therapies in the 
T2D patient group at the time of  skin resection, some (n = 3) were taking angiotensin converting enzyme 
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(ACE) inhibitor therapies, some (n = 3) were taking diuretics, and one was taking an angiotensin II receptor 
blocker therapy. For the control group at the time of  skin resection, most (n = 7) were not taking any thera-
pies, and one was taking a diuretic and ACE inhibitor therapy.
Each skin sample (measuring approximately 2 × 2 × 0.5 cm3) was vacuum packed to preserve its nat-
ural sodium distribution, stored on ice, and delivered on ice to SPMIC, via courier within 2 hours of  sur-
gical resection. We scanned all skin samples (as described below) at 37°C, after their delivery to SPMIC. 
We checked the viability of  vacuum-packed tissues by 1-dimensional 23Na MRS using “1-pulse acquire 
sequence” to characterize free sodium and TQF sequence for bound sodium. Prior to performing the exper-
iments, we observed no difference in spectra between scanning upon the arrival, after 1 day of  keeping the 
tissues at 37°C and following storage of  the samples at a refrigerated (5°C) temperature for 1 week.
General NMR and MRI. Nuclear magnetic resonance (NMR) and MRI of  all spin species reported in this 
study were performed on a 9.4 T Bruker Avance III Microimaging system (Bruker). We used single-channel 
25 mm commercial microimaging coils (Bruker) and a dual tuned 1H/23Na microimaging coil (Bruker). We 
used coils tuned to the resonance frequency of  400.18 MHz for protons and 105.86 MHz for sodium for all 1H 
and 23Na skin sample studies. The length of  the 1H π/2 pulse was 32 μs at 150 W, the dwell time was set to 40 
μs, and the resonance offset was set at the maximum of the proton peak height associated with water phase in 
each experiment, or a series of  consecutive experiments. Usually, we observed 2 proton peaks associated with 
the aqueous and the lipid phases in the 1-dimensional proton spectrum. The length of  the 23Na π/2 hard pulse 
was 48 μs at 200 W, the dwell time was set to 80 μs, and the resonance offset was set at the maximum of the 
sodium peak height in each experiment — or a series of  consecutive experiments, as we observed only 1 peak. 
We performed all sodium experiments at 37°C unless otherwise stated. We have provided specific experimen-
tal spectroscopic and imaging details below.
1H MRI. Anatomical images were acquired using Paravision 6.0 (Bruker). We performed each ana-
tomical imaging protocol using a build-in multislice GE imaging protocol with slice thickness of  200 
μm. Each anatomical experiment contained up to 30 slices, to highlight possible heterogeneities in the 
skin biopsy structure. The images were acquired using full π/2 flip angle, with Time to Echo (TE) = 8 
ms. Recycle delay was set to 800 ms to ensure 3T1 delay between successive pulses, and it was repeated 
4 times to achieve satisfactory image quality. We acquired time domain data into 512 × 512 matrices, 
processed off-line using Prospa 3.2 (Magritek) to result in the magnitude images presented in this study. 
Final in-plane image resolution was < 20 μm2. T2* contrast data were acquired using the same exper-
imental protocol. We collected 10 in-plane echoes to reconstruct a full relaxational picture in different 
anatomical regions of  the skin. Only positive echoes were used for T2* analysis. Final images were ana-
lyzed exponentially in each voxel using Prospa 3.2, resulting in the maps highlighting different relaxation 
behaviors in each skin region. The T2* images were converted into histograms and then further analyzed 
with a build-in Multipeak fitting routine in IgorPro8.2 (Wavemetrics).
23Na MRS. We used a TopSpin 3.2 (Bruker) home-written 2-dimensional TQ-TPPI sequence (23, 25) 
to determine the fraction of  sodium in the bound state in all skin biopsies. Spectral width in the direct 
dimension was set to 4 KHz, the indirect dimension was incremented using 256 200 μs time increments, 
recycle delay was 0.1 seconds, and the spectra were collected under 2 minutes. Data were processed with 
TopSpin3.2, with zero filling data in both dimensions. Line broadening was 5 Hz in doth dimensions, with 
spectra manually phased in both dimensions. We derived fractions of  bound and free sodium by analyzing 
central traces extracted at zero frequency in the direct dimension, using a build-in Multipeak fitting routine 
in IgorPro8.2. We used normalized intensities of  Lorentzian distributions (32) obtained during spectral 
deconvolution as fractions of  bound and free sodium.
23Na MRI. We performed localization of  free sodium with TopSpin 3.2 (Bruker) using a home-written 
nonselective GE MRI protocol. The width of  the π/2 pulse was 54 μs, the recycle delay was 0.2 seconds, 
and the spectral width was 25 kHz. We collected images into 64 × 64 matrices with the phase-encoding 
time of  1.2 ms and maximum phase and read gradients set to 5% and 6%, respectively, resulting in a field of  
view (FOV) of  32 × 25 mm2. We accumulated 512 transients (image collection within 2 hours). We recon-
structed images in Prospa 3.2 (Magritek) by zero filling to 256 × 256 matrices; sinc-squared apodization 
was performed in both dimensions with consecutive magnitude 2-dimensional Fourier transformation. The 
resolution of  the processed images was approximately 0.125 × 0.098 mm2 in the axial plane.
We performed visualization of  bound sodium using a TopSpin 3.2 (Bruker) home-written code, with 
application of  TQF before localization of  bound sodium with the GE. We set the evolution time to that 
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determined in TQF 23Na MRS, by identifying the appropriate evolution time τ where the TQ signal was 
at maximum. The width of  the π/2 pulse was 49 μs, with the width of  π pulse in the TQF set to 98 μs, the 
TQF evolution time τ was set to 3 ms, the recycle delay was 0.2 seconds, and the spectral width was 50 
kHz. We collected axial images into 128 × 32 matrices with the phase encoding time of  1.2 ms — with 
maximum phase and read gradients set to 4% and 5%, respectively — resulting in a FOV of  19 × 60 mm2. 
We accumulated 960 transients (image collection within 2 hours). We reconstructed images in Prospa 3.2 
by zero filling to 256 × 256 matrices and sinc-squared apodization performed in both dimensions with 
consecutive magnitude 2-dimensional Fourier transformation. The resolution of  the processed images was 
approximately 0.074 × 0.234 mm2 in the axial plane.
Histocytochemical analysis. To provide further insight into the colocalization of  MRI-based sodium sig-
nals with GAG molecules within the skin dermis layer, we performed histocytochemical staining for GAG 
molecules within one of  the skin samples from a control participant. For this, we used the Alcian blue tech-
nique for staining acid mucins. Following dewaxing, we placed precut sections of  skin in distilled water. We 
stained each section in Alcian blue solution (pH 2.5) for 15–20 minutes. Following rinsing in distilled water, 
we then applied a counterstain in 1% neutral red for 1–2 minutes, rinsed well in distilled water, dehydrated, 
cleared, and mounted each skin section. For the histocytochemistry analysis, blue positivity indicates the 
presence of  acid mucins (including GAG molecules). To provide an indication of  colocalization of  MRI-
based sodium signals with GAG staining, we superimposed the GAG stained images with 23Na MRI slides 
obtained for both free and bound sodium states.
Statistics. We performed all statistical analyses using IgorPro8.2. Samples of  fractions of  free and bound 
sodium in skin biopsies were extracted from the analysis of  2-dimensional 23Na TQ-TPPI and were subjected 
to the following tests to determine a final statistical approach for the interpretation of  data presented in this 
study within a significance level of  α = 0.05. A serial randomness test suggested that the samples were ran-
dom. The Kolmogorov–Smirnov test rejected a hypothesis of  normal distribution in all samples. The F test 
suggested unequal variances in both samples. Therefore, we used a Wilcoxon signed-rank test rather than t 
test for determination of  validity of  the null hypothesis.
Multi-element analysis by ICPMS was performed using Thermo Fisher iCAP-Q with a Flatopole 
collision cell (typically charged with helium gas) upstream of  the analytical quadrupole to reduce poly-
atomic interferences. Internal standards are normally introduced to the sample stream via a T-piece 
and typically include Scandium (Sc; 50 μg/L), Germanium (Ge; 20 μg/L), Rhodium (Rh; 10 μg/L), 
and Iridium (Ir; 5 μg/L) in the preferred matrix of  2% HNO3; similar concentration levels of  HCl are 
also acceptable. We used external calibration standards in the usual range of  0–100 μg/L (ppb). We 
introduced samples using a covered autosampler (Cetac ASX-520), through either a concentric glass 
venturi nebulizer (Thermo Fisher Scientific) or a PEEK Burgener Miramist nebulizer. We performed 
further sample analysis using Qtegra Intelligent Scientific Data Solution Software (Thermo Fisher Sci-
entific). Skin region samples for ICPMS were prepared using small quantities of  3 major skin regions 
(≤0.4 g), weighed directly in Digitubes using Analytical balance. Subsequently, 8 mL of  nitric acid 
(HNO3, trace metal grade) and 2 mL of  hydrogen peroxide (H2O2, metal grade), were added to each 
solid phase skin sample, which were then left overnight. We heated each sample for 2 hours at 95°C 
and then left the samples for 10 minutes to cool down. Subsequently, we added Milli-Q (MilliporeSig-
ma) water to bring the final volume in each digested sample to 50 mL. We also added Milli-Q water 
directly to the harvested plasma samples (derived from the vacuum packs used to transport each skin 
sample so no digestion was required), to make a volume of  10 mL. Outcomes of  sodium levels in the 
various skin regions are presented in Table 2.
Study approval. We obtained the skin samples from the Arden tissue bank, located at UHCW, with 
patient consent obtained prior to lower limb amputation or abdominal skin reduction surgery. We obtained 
ethical approval from West Midlands Research Ethics Committee, United Kingdom.
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